ORIC Pharmaceuticals, Inc.
ORIC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $59 | $23 | $67 | $226 |
| Short-Term Investments | $197 | $185 | $139 | $11 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $4 | $4 | $4 |
| Total Curr. Assets | $262 | $213 | $210 | $241 |
| Property Plant & Equip (Net) | $3 | $12 | $14 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $27 | $22 | $43 |
| Tax Assets | $0 | $3 | $3 | $0 |
| Other NC Assets | $9 | $0 | $0 | $12 |
| Total NC Assets | $12 | $42 | $40 | $58 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $274 | $255 | $250 | $299 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $1 | $2 |
| Short-Term Debt | $3 | $3 | $3 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $20 | $17 | $11 | $11 |
| Total Curr. Liab. | $25 | $20 | $15 | $15 |
| LT Debt | $0 | $7 | $9 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $3 | $3 | $0 |
| Other NC Liab. | $6 | $0 | $0 | $11 |
| Total NC Liab. | $6 | $10 | $13 | $11 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $7 | $9 | $2 |
| Total Liabilities | $31 | $31 | $28 | $26 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$563 | -$435 | -$334 | -$245 |
| AOCI | $0 | $0 | -$1 | -$0 |
| Other Equity | $806 | $659 | $558 | $518 |
| Total Equity | $243 | $224 | $222 | $273 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $274 | $255 | $250 | $299 |
| Net Debt | -$56 | -$13 | -$55 | -$224 |